Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.91% Nasdaq Up 0.87%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS

210.80 Up 3.05(1.47%) 4:00PM EDT|After Hours : 210.81 Up 0.01 (0.00%) 6:42PM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:207.75
Open:207.51
Bid:208.00 x 200
Ask:217.39 x 100
1y Target Est:235.71
Beta:1.23
Next Earnings Date:22-Jul-13BIIB Earnings announcement
Day's Range:206.43 - 211.62
52wk Range:134.00 - 242.64
Volume:1,440,775
Avg Vol (3m):1,476,040
Market Cap:50.04B
P/E (ttm):33.45
EPS (ttm):6.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 1.47%50.04B
RHHBYN.MXUp 1.64%2.74T
SHP.LDown 0.38%11.51B
SUNPHARMA.NSDown 0.08%1.00T
GILD.MXUp 2.37%1.02T

Key Statistics

Forward P/E (1 yr):20.81
P/S (ttm):8.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :8.11
Quarterly EPS Est (Jun-13) :1.90
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback